Sanofi stock up; Bristol-Myers stock off
677736
Shares of Sanofi-Aventis rose and Bristol-Myers Squibb stock tumbled Monday after a report that the French drugmaker had called off talks on a possible combination with the U.S.-based company.
9086
Stocks inched higher Tuesday as investors saw the bright side of mixed economic data and rumors about big merger deals, including a report that consumer products giant Johnson &amp; Johnson&#39;s is in talks to purchase a leading medical device maker.
503333
Boston Scientific Corp. stock rose more than 5 per cent Wednesday after company executives called a recent recall of its Taxus heart stents a blip and said most of the lost market share has already been recovered.
449256
GlaxoSmithKline PLC, the world's second-largest drug maker, began a campaign to challenge a report that linked its diabetes drug Avandia to heart risks and caused its stock to decline 11 percent in the eight days through Tuesday. The shares rose yesterday.
557154
U.S. stocks held solid gains on  Wednesday, as oil prices held below $42 a barrel and healthcare  stocks rose, with shares of drugmaker Merck & Co. MRK.N up  after issuing a 2005 forecast that was better than some  analysts had expected.
498346
Vanda Pharmaceuticals, which went public in April at $10 a share, has seen that price soar to more than $26 in the past month after reporting positive late-stage test results for two of its drugs.
96706
U.S. stock indexes rose on Monday as takeover news and strong profits from blue-chip companies, including Merck & Co. , reassured investors after Friday's sell-off.
531813
U.S. stocks ended higher on Wednesday,  with the dollar strengthening and shares of drugmaker Merck &  Co. MRK.N helping to lift the blue-chip Dow after the company  issued a forecast that was not as weak as some investors had  expected.
524340
NEW YORK, September 1 (New Ratings) - Boston Scientificâs (BSX.NYS) share price rose more than 6% on the news of market share regains by Taxus, the company&#39;s drug-coated stent.
738837
U.S. blue chip stocks rose on  Wednesday, helped by drugmaker Merck & Co. Inc. MRK.N, but  technology stocks fell as results from technology bellwether  Cisco Systems Inc. CSCO.O disappointed Wall Street.
757586
Sanofi gains a crucial legal victory for its top compound.
421295
U.S. stocks rose on Monday as several major corporate deals pointed to optimism about the economy, outweighing sharp losses by blue-chip Pfizer Inc.  after the world's No. 1 drug company dropped a key experimental product.
441955
Bristol-Myers announces a 22% rise in Q3 revenue as Plavix sales continue to rise.
738503
YESTERDAY Close $54.64 Change +$1.53 52-WEEK High $55.14 Low $42.29 Merck &amp; Co., the third-largest US drug maker, reported a 63 percent increase in earnings and raised its forecast for the year after a vaccine for cervical cancer and a new pill for diabetes drove sales higher.
662710
Shares of Medarex Inc. rose over 11 percent before the market opened Monday after the company said it and Bristol-Myers Squibb Co.
50160
European stocks were slightly lower by mid-day in holiday-hit trading on Monday, with crude oil rises weighing on shares, though Sanofi-Aventis gained on the result of trials of an anti-obesity drug.
122847
Socks rose on Tuesday as European companies made takeover offers for U.S. companies in the health-care and chemicals sectors and bond yields dipped, sending rate-sensitive stocks higher.